Patients with childhood and young adult cancer have an increased long-term risk for diabetes, noted as early as 10 years ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “A case report of donor cell–derived ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Mikkael A. Sekeres, MD, Sylvester Comprehensive Cancer Center, discusses the potential benefits of treosulfan, a newly ...

A recent study published in the recent issue of Diabetes Care journal revealed a significant long-term risk of diabetes among ...

Hematopoietic stem cell transplantation (HSCT) is a vital treatment for both malignant and non-malignant disorders in pediatric patients.

Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...

Orca Bio announces it met the primary endpoint in its pivotal Phase 3 clinical study for its lead allogeneic T-cell immunotherapy, Orca-T.

tumor effects to wipe out cancer cells. These can be conducted as an outpatient ... Dr. Storb’s legacy is continued through world-wide advances in hematopoietic stem cell transplantation and ...

Researchers find that certain antioxidant enzymes, called selenoproteins, significantly contribute to fighting cell aging. The team used a gene knockout mouse model to help them study the effects of ...

Many foods are often advertised for their antioxidant properties. Antioxidants counteract what are known as reactive oxygen ...